{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Dr Agarwals Health Care Ltd
Dr Agarwals Health Care Ltd’s Mixed Week: -0.46% Price, -0.28% Sensex Tell the Story
Dr Agarwals Health Care Ltd experienced a volatile week from 16 to 20 March 2026, closing marginally lower by 0.46% at Rs.424.25, slightly underperforming the Sensex’s 0.28% decline. The week was marked by significant technical developments, including a bearish Death Cross formation and a rating upgrade followed by a downgrade by MarketsMOJO, reflecting mixed signals amid strong financials and valuation concerns.
Dr Agarwals Health Care Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
Dr Agarwals Health Care Ltd has seen its investment rating downgraded from Buy to Hold as of 18 March 2026, reflecting a nuanced reassessment across key parameters including technical trends, valuation, financial performance, and overall quality. While the company continues to demonstrate robust financial results and healthy growth, evolving market dynamics and technical indicators have prompted a more cautious stance among analysts.
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Market Pressure
Dr Agarwals Health Care Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. This transition is underscored by a series of bearish signals across key technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling caution for investors amid recent price declines and underperformance relative to the broader market.
Dr Agarwals Health Care Ltd Forms Death Cross, Signalling Bearish Momentum
Dr Agarwals Health Care Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s momentum and raising concerns about its long-term strength amid challenging market conditions.
Dr Agarwals Health Care Ltd Upgraded to Buy on Strong Financials and Technical Shift
Dr Agarwals Health Care Ltd has been upgraded from a Hold to a Buy rating, reflecting a notable improvement in its technical outlook alongside robust financial performance. The upgrade, announced on 13 March 2026, is underpinned by positive shifts across four key parameters: quality, valuation, financial trend, and technical indicators. This comprehensive reassessment highlights the company’s growing appeal within the hospital sector despite recent market volatility.
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals
Dr Agarwals Health Care Ltd, a small-cap player in the hospital sector, has recently experienced a shift in its technical momentum from mildly bearish to mildly bullish. Despite a day-on-day price decline of 2.55%, the stock’s technical indicators reveal a nuanced picture, with mixed signals from MACD, RSI, moving averages and other trend-following tools. This article analyses the evolving technical landscape and what it means for investors navigating the current market environment.
Dr Agarwals Health Care Ltd is Rated Buy
Dr Agarwals Health Care Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 March 2026, providing investors with the latest insights into its performance and outlook.
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals
Dr Agarwals Health Care Ltd has experienced a subtle but notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a combination of bearish weekly MACD and Bollinger Bands signals, alongside mixed readings from moving averages and volume indicators, prompting a downgrade in its Mojo Grade from Buy to Hold as of 2 March 2026.
Dr Agarwals Health Care Ltd Falls 2.16%: Valuation and Technical Shifts Shape Weekly Performance
Dr Agarwals Health Care Ltd closed the week down 2.16% at Rs.441.70, underperforming the broader Sensex which fell 3.00%. The stock experienced volatile trading amid a downgrade to Hold by MarketsMOJO and a shift in technical momentum from bullish to sideways. Despite strong underlying financials, valuation concerns and mixed technical indicators weighed on investor sentiment during the week ending 6 March 2026.
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals
Dr Agarwals Health Care Ltd has recently exhibited a shift in its technical momentum, transitioning from a previously bullish stance to a more sideways trend. This change is underscored by a complex interplay of technical indicators, including bearish signals from the MACD and Bollinger Bands on weekly charts, contrasted by mildly bullish daily moving averages. Investors and analysts are now carefully weighing these mixed signals as the stock navigates a challenging phase within the hospital sector.
Dr Agarwals Health Care Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
Dr Agarwals Health Care Ltd has seen its investment rating downgraded from Buy to Hold as of 2 March 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and healthy institutional backing, evolving technical signals and valuation concerns have tempered investor enthusiasm.
When is the next results date for Dr Agarwals Health Care Ltd?
The next results date for Dr Agarwals Health Care Ltd is February 3, 2026.
Why is Dr Agarwal's Hea falling/rising?
On 28-Nov, Dr Agarwals Health Care Ltd witnessed a notable rise in its share price, closing at ₹531.50, up ₹6.20 or 1.18% as of 09:23 PM. This upward movement reflects sustained investor confidence and robust trading activity, positioning the stock well above key technical benchmarks.
Why is Dr Agarwal's Hea falling/rising?
As of 06-Nov, Dr Agarwals Health Care Ltd's stock price is Rs 508.60, down 1.22%, with a recent decline in investor participation and performance worse than its sector. Despite a 3.55% gain over the past month, the stock's recent downward trend and reduced trading volume indicate cautious investor sentiment.
How has been the historical performance of Dr Agarwal's Hea?
Dr Agarwal's Hea has shown significant growth over the past three years, with net sales increasing from 1,017.98 Cr in Mar'23 to 1,711.00 Cr in Mar'25, and operating profit rising from 283.86 Cr to 502.40 Cr during the same period, alongside a substantial increase in total assets. Overall, the company demonstrates a solid performance trajectory with rising revenues and profits.
Why is Dr Agarwal's Hea falling/rising?
As of 10-Oct, Dr Agarwals Health Care Ltd is experiencing a price increase to Rs. 533.00, reflecting a rise of 6.02% and hitting a new all-time high of Rs. 542. The stock has shown strong performance with a 6.72% gain over the past week and a 24.36% surge in the last month, outperforming its sector and the benchmark Sensex.
Why is Dr Agarwal's Hea falling/rising?
As of 25-Sep, Dr Agarwals Health Care Ltd is currently priced at Rs 482.05, reflecting a 4.7% increase. Despite outperforming the market, a significant drop in delivery volume raises concerns about sustained investor interest.
Why is Dr Agarwal's Hea falling/rising?
As of 24-Sep, Dr Agarwals Health Care Ltd is priced at 459.25, down 0.21%, but has shown a strong 3.94% return over the past week, outperforming the Sensex. The stock is trading above key moving averages and has seen a significant increase in investor interest, indicating a potentially positive outlook despite the current decline.
Why is Dr Agarwal's Hea falling/rising?
As of 23-Sep, Dr Agarwals Health Care Ltd is trading at 459.40, reflecting a 0.85% increase and outperforming its sector. Despite a decline in investor participation, the stock shows strong upward momentum and adequate liquidity for trading.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
